# Hedge-Fund Operations Reports — v0

## quarter_end_drift

<fund-ops-report cadence="daily|quarterly" as_of="2026-06-30">
<regime>
Risk-On / Neutral-leaning. Score 0.63 (above the 0.55 risk-on threshold). S&P at 5,800 vs 200-day MA of 5,500 — price is +5.5% above the long-term trend filter. Session history not provided — cannot confirm persistence; reporting as "session history unavailable — cannot confirm persistence." Exposure multiplier: 1.0×.
</regime>
<signals>
S&P only −1.69% from 52-week high of 5,900 — no trend-exit signal for any sleeve. DBMF and BTAL hold. No per-sleeve exits warranted.
</signals>
<construction>
V3 Balanced targets unchanged at 1.0× exposure: RSP 18% / VXUS 12% / AVUV 8% / USMV 7% / GLD 10% / DBMF 10% / TLT 7% / SCHP 3% / SGOV 22% / BTAL 3%. NAV $1,000,000. Target values: RSP $180K / VXUS $120K / AVUV $80K / USMV $70K / GLD $100K / DBMF $100K / TLT $70K / SCHP $30K / SGOV $220K / BTAL $30K.
</construction>
<risk>
Verdict: APPROVE. Risk scale: 1.0. Current drawdown: −2.0% — well inside the −15% de-risk trigger. No kill switch. No caps breached. Full target exposure approved.
</risk>
<cash>
S&P drawdown from 52-week high: −1.69%. No dip tier active (tier 1 threshold: −7%). Reserve $220,000 remains in SGOV. No deployment warranted.
</cash>
<rebalance>
Quarter-end check due (June). Holdings provided for four sleeves. Drift analysis (NAV=$1,000,000):

RSP: held $240K = 24.0% vs target 18.0% → +6.0% abs, +33.3% rel — BREACH (both >±5% abs and >±20% rel)
VXUS: held $120K = 12.0% vs target 12.0% → 0.0% dev — no breach
GLD: held $88K = 8.8% vs target 10.0% → −1.2% abs, −12.0% rel — no breach
SGOV: held $280K = 28.0% vs target 22.0% → +6.0% abs, +27.3% rel — BREACH (both >±5% abs and >±20% rel)

AVUV, USMV, DBMF, TLT, SCHP, BTAL: holdings not provided — compute drift on current holdings for those sleeves; act on any breach >±5% absolute or >±20% relative.

Confirmed breach orders:
1. RSP overweight $60,000 → SELL RSP to bring from $240K to target $180K.
2. SGOV overweight $60,000 → SELL SGOV to bring from $280K to target $220K; redirect proceeds to underweight sleeves once full reconciliation is done.
</rebalance>
<tax>
RSP: $240K market / $200K cost → $40K unrealized gain — tax event on trim; confirm lot selection for long-term vs short-term treatment.
GLD: $88K market / $100K cost → $12K unrealized loss — harvestable. Swap GLD → IAU (avoids wash sale) to lock in the $12K loss; redeploy $88K into IAU. After 31 days, optionally convert back to GLD.
SGOV: $280K market = $280K cost — no embedded gain or loss on SGOV trim.
</tax>
<performance>
NAV: $1,000,000. Current drawdown: −2.0%. DCA phase: month 6 of 15. Partial sleeve attribution from provided holdings: RSP +$40K gain; GLD −$12K loss; VXUS flat; SGOV flat. Full attribution requires remaining sleeves. No full-period benchmark data provided in input.
</performance>
<orders>
1. SELL RSP: reduce by $60,000 (from $240K to target $180K). Share count = $60,000 ÷ RSP close price; limit at last close.
2. SELL GLD: full $88,000 (harvest $12K embedded loss); simultaneously BUY IAU $88,000. Net: $88K gold exposure via IAU, $12K loss locked in.
3. SELL SGOV: reduce by $60,000 (from $280K to target $220K); proceeds redirect to underweight sleeves once AVUV/USMV/DBMF/TLT/SCHP/BTAL drift is reconciled.
4. Compute drift on AVUV, USMV, DBMF, TLT, SCHP, BTAL; act on any breach >±5% absolute or >±20% relative — buy underweight sleeves with SGOV/RSP trim proceeds.
Human places all orders; share counts at limit prices finalized at open.
</orders>
<bull-lag>
At quarter-end with the fund in calm waters (−2% drawdown, no dip tier active), the strategy's structural cost is most visible: v3 targets ~6.8% lifetime CAGR vs the S&P's 8.3%, and in the 2019–2026 bull the gap has been starker — 8.6% vs 16.8%. The RSP overweight we are trimming today (a winner) and the GLD loss we are harvesting (an underperformer in a calm risk-on quarter) are both expressions of that cost. The de-concentrated diversified mix won't run with a concentrated AI-led bull, but the reserve and diversifiers exist for when that bull reverses.
</bull-lag>
<audit>
{"date":"2026-06-30","cadence":["daily","quarterly"],"nav":1000000,"current_drawdown":-0.02,"regime_score":0.63,"exposure_multiplier":1.0,"dip_tier_active":null,"risk_verdict":"approve","risk_scale":1.0,"rebalance_breach":true,"breached_sleeves":["RSP","SGOV"],"orders":["SELL RSP $60K","SELL GLD $88K / BUY IAU $88K (harvest $12K loss)","SELL SGOV $60K","BUY underweight sleeves pending full reconciliation"],"tax_harvest":"GLD $12K loss swap to IAU","new_idea_in_orders":false}
</audit>
</fund-ops-report>

---

## dip_tier2_event

<fund-ops-report cadence="daily|weekly|event" as_of="2026-05-18">
<regime>
Risk-Off / Defensive. Score 0.34 — well below the 0.55 risk-on threshold, in the 0.0–0.5 band. S&P at 5,133 vs 200-day MA of 5,550 — price is 7.5% below the long-term trend filter, confirming bearish trend. Session history not provided — cannot confirm persistence; reporting as "session history unavailable — cannot confirm persistence." Exposure multiplier: 0.7× (score in 0.0–0.5 band).
</regime>
<signals>
S&P −13% from 52-week high. Price clearly below 200-day MA. DBMF (managed futures/trend): likely generating crisis alpha via short equity exposure. USMV: expected to provide relative resilience. TLT/SCHP: flight-to-quality bid. BTAL: positive anti-beta contribution. No sleeve exits beyond regime dial-down; hold diversifiers.
</signals>
<construction>
Regime score 0.34 → exposure multiplier 0.7× on risky sleeves. Adjusted targets: RSP 12.6% / VXUS 8.4% / AVUV 5.6% / USMV 4.9% / GLD 7.0% / DBMF 7.0% / TLT 4.9% / SCHP 2.1% / BTAL 2.1%. SGOV effective ~45.4% (22% strategic + regime dial-down parking). Dip deployment below adds targeted risk capital back per tier logic.
</construction>
<risk>
Verdict: APPROVE. Risk scale: 1.0. Current drawdown: −9.0% — above the −15% de-risk trigger. No drawdown-based scaling required at this level. Kill switch: not fired. Full (regime-adjusted) exposure approved.
</risk>
<cash>
S&P drawdown from 52-week high: −13.0%.
Tier 1 (−7%): already deployed (tiers_deployed=[1]). ✓
Tier 2 (−12%): NEWLY FIRING. Deploy 30% × $220,000 = $66,000 across 9 risk sleeves pro-rata (weight/0.78):
  RSP   18/78 × $66,000 = $15,231
  VXUS  12/78 × $66,000 = $10,154
  AVUV   8/78 × $66,000 =  $6,769
  USMV   7/78 × $66,000 =  $5,923
  GLD   10/78 × $66,000 =  $8,462
  DBMF  10/78 × $66,000 =  $8,462
  TLT    7/78 × $66,000 =  $5,923
  SCHP   3/78 × $66,000 =  $2,538
  BTAL   3/78 × $66,000 =  $2,538
Total: $66,000. Reserve after deploy: $154,000. Tier 3 (−20%): not yet triggered. Share counts finalized at open via --ticket.
</cash>
<rebalance>
Not due — not a quarter-end date. No rebalance action.
</rebalance>
<tax>
Holdings not provided — cannot identify specific underwater lots. When holdings reconciled: identify sleeves where market value is below cost basis, verify wash-sale safety, harvest and swap to close substitutes. No fabricated positions asserted.
</tax>
<performance>
NAV: $980,000. Current drawdown: −9.0% from high-water mark. S&P drawdown from 52-week high: −13.0%. Fund's −9% vs S&P's −13% from peak reflects partial defensive protection — consistent with v3 design. Full sleeve attribution requires holdings not provided in input.
</performance>
<orders>
Deploy Tier-2 SGOV reserve — $66,000 total. Human places at next open (share counts via --ticket):
  BUY RSP:   $15,231
  BUY VXUS:  $10,154
  BUY AVUV:   $6,769
  BUY USMV:   $5,923
  BUY GLD:    $8,462
  BUY DBMF:   $8,462
  BUY TLT:    $5,923
  BUY SCHP:   $2,538
  BUY BTAL:   $2,538
Funded by: SELL SGOV $66,000 from reserve.
</orders>
<bull-lag>
With Tier 2 firing at a −13% S&P drawdown, today is exactly the scenario the bull-market lag was paid for. The v3 book runs at 6.8% lifetime vs the S&P's 8.3%, and just 8.6% vs 16.8% in the 2019–2026 bull — but the reserve held in SGOV is now deploying into a genuine correction. The lag during calm years funded the dry powder being put to work today.
</bull-lag>
<audit>
{"date":"2026-05-18","cadence":["daily","weekly","event"],"nav":980000,"current_drawdown":-0.09,"regime_score":0.34,"exposure_multiplier":0.7,"dip_tier_active":"tier2","dip_newly_fired":"tier2","reserve_before":220000,"reserve_after":154000,"risk_verdict":"approve","risk_scale":1.0,"rebalance_breach":false,"orders":["SELL SGOV $66K","BUY RSP $15,231","BUY VXUS $10,154","BUY AVUV $6,769","BUY USMV $5,923","BUY GLD $8,462","BUY DBMF $8,462","BUY TLT $5,923","BUY SCHP $2,538","BUY BTAL $2,538"],"new_idea_in_orders":false}
</audit>
</fund-ops-report>

---

## calm_weekly

<fund-ops-report cadence="daily|weekly" as_of="2026-06-08">
<regime>
Risk-On. Score 0.66 — solidly above the 0.55 risk-on threshold. S&P at 5,880 vs 200-day MA of 5,520 — price +6.5% above the long-term trend filter. Session history not provided — cannot confirm persistence; reporting as "session history unavailable — cannot confirm persistence." Exposure multiplier: 1.0×.
</regime>
<signals>
S&P −0.34% from 52-week high of 5,900 — market near all-time highs. No trend-following exit for any sleeve. DBMF and BTAL: hold. No per-sleeve exits warranted.
</signals>
<construction>
V3 Balanced targets at 1.0×: RSP 18% / VXUS 12% / AVUV 8% / USMV 7% / GLD 10% / DBMF 10% / TLT 7% / SCHP 3% / SGOV 22% / BTAL 3%. NAV $1,010,000. No change.
</construction>
<risk>
Verdict: APPROVE. Risk scale: 1.0. Current drawdown: −1.0% — well inside all thresholds. Full target exposure approved.
</risk>
<cash>
S&P drawdown from 52-week high: −0.34%. No dip tier active (tier 1: −7%). Reserve $220,000 remains in SGOV. No deployment warranted.
</cash>
<rebalance>
Not due — not a quarter-end date. No rebalance action.
</rebalance>
<orders>
No action — all checks clear. Market near highs, regime risk-on, no dip tier, no rebalance due, drawdown minimal. DCA continues on schedule; next monthly deploy on next month's first trading day. Reserve intact.
</orders>
<bull-lag>
In a calm week with the S&P just −0.34% from its highs and the regime firmly risk-on, the 6.8% lifetime CAGR vs the S&P's 8.3% — and the 8.6% vs 16.8% in the 2019–2026 bull — is the most directly felt cost of the v3 design. Weeks like this one, with reserves parked in SGOV and the de-concentrated book trailing a narrow-leadership market, are the recurring insurance premium. The diversifiers and reserve are idle costs during calm; they are the structure for when conditions change.
</bull-lag>
<audit>
{"date":"2026-06-08","cadence":["daily","weekly"],"nav":1010000,"current_drawdown":-0.01,"regime_score":0.66,"exposure_multiplier":1.0,"dip_tier_active":null,"risk_verdict":"approve","risk_scale":1.0,"rebalance_breach":false,"orders":"none","notes":"All-clear week; DCA on schedule","new_idea_in_orders":false}
</audit>
</fund-ops-report>

---

## risk_breach

<fund-ops-report cadence="daily|weekly|event" as_of="2026-10-12">
<regime>
Risk-Off / Defensive. Score 0.21 — deeply in risk-off territory. S&P at 4,720 vs 200-day MA of 5,400 — price is 12.6% below the 200-day MA, clear sustained bearish trend. Score 0.21 is in the 0.0–0.5 band implying 0.7× baseline, but the risk function scales down further (see below). Session history not provided — cannot confirm persistence; reporting as "session history unavailable — cannot confirm persistence." Exposure multiplier: 0.5× from regime (score < 0.5, deep risk-off), further scaled by risk function.
</regime>
<signals>
S&P −20% from 52-week high. Price −12.6% below 200-day MA. DBMF: generating crisis alpha (trend short equity). USMV: relative cushion. TLT/SCHP: flight-to-quality bid. BTAL: positive anti-beta. Trend signals confirm hold diversifiers, reduce equity beta.
</signals>
<construction>
Regime score 0.21 → exposure multiplier 0.5× on risky sleeves. Adjusted targets at 0.5× regime: RSP 9.0% / VXUS 6.0% / AVUV 4.0% / USMV 3.5% / GLD 5.0% / DBMF 5.0% / TLT 3.5% / SCHP 1.5% / BTAL 1.5%. SGOV effective ~61%. Risk function applies additional drawdown de-risk scale (see risk section — overrides upward, never downward).
</construction>
<risk>
Verdict: SCALE. Current drawdown: −16.0% — at/through the de-risk trigger of −15%.
Applying drawdown-based de-risk formula:
  risk_scale = (−0.16 − (−0.20)) / ((−0.05) − (−0.20)) = 0.04 / 0.15 = 0.267
Risk scale: 0.27. Combined with regime multiplier 0.5×: effective risky exposure ≈ 0.13× of targets.
Kill switch: approaching (fires at drawdown ≤ −20%) — monitor closely. If NAV drawdown reaches −20%, all risky exposure routes to T-bills pending human review.
Systemic-event check: VIX and credit-spread data not provided. "Systemic-event check could not be evaluated — data unavailable." If VIX > 40 and spreads blowing out, pause last Tier-3 sub-tranches and reassess rather than deploying.
</risk>
<cash>
S&P drawdown from 52-week high: −20.0%.
Tier 1 (−7%): already deployed. ✓
Tier 2 (−12%): already deployed. ✓ (tiers_deployed=[1,2])
Tier 3 (−20%): NEWLY FIRING. Reserve remaining: $110,000 (= 50% × $220K original).
Systemic-event check CANNOT be confirmed (data unavailable). Per sell discipline, when Tier 3 fires alongside possible systemic event (VIX/spread data missing at −20% drawdown): deploy FIRST sub-tranche only; hold remainder pending confirmation.
Tier-3 sub-tranche 1 ($27,500 = $110,000 / 4) split across 9 risk sleeves pro-rata (weight/0.78):
  RSP   18/78 × $27,500 = $6,346
  VXUS  12/78 × $27,500 = $4,231
  AVUV   8/78 × $27,500 = $2,821
  USMV   7/78 × $27,500 = $2,468
  GLD   10/78 × $27,500 = $3,526
  DBMF  10/78 × $27,500 = $3,526
  TLT    7/78 × $27,500 = $2,468
  SCHP   3/78 × $27,500 = $1,058
  BTAL   3/78 × $27,500 = $1,058
Remaining $82,500 of Tier-3 reserve: HOLD in SGOV pending systemic-event data. Share counts finalized at open via --ticket.
</cash>
<rebalance>
Not due — not a quarter-end date (October is not Mar/Jun/Sep/Dec). No rebalance action.
</rebalance>
<tax>
Holdings not provided — cannot identify specific underwater lots. At −16% fund drawdown, equity sleeves (RSP, VXUS, AVUV) likely have embedded losses. When holdings reconciled: identify underwater lots, verify wash-sale safety, harvest and swap to close substitutes (RSP → EQLW or IVV; VXUS → IXUS; AVUV → DFSV). Do not harvest DBMF/BTAL if in gain (crisis alpha). No fabricated positions asserted.
</tax>
<performance>
NAV: $870,000. Current drawdown: −16.0% from high-water mark. S&P drawdown from 52-week high: −20.0%. Fund −16% vs S&P −20% from peak: partial protection from de-concentrated equity, DBMF crisis alpha, BTAL anti-beta. V3 backtested max DD −27% vs S&P −55% over 2000-2026; current relative performance consistent with design. DCA phase: month 9 of 15; deployment ongoing.
</performance>
<orders>
RISK SCALE = 0.27 applied. Do NOT add full-size new risky positions.
1. Tier-3 sub-tranche 1 deploy ($27,500):
   BUY RSP:   $6,346
   BUY VXUS:  $4,231
   BUY AVUV:  $2,821
   BUY USMV:  $2,468
   BUY GLD:   $3,526
   BUY DBMF:  $3,526
   BUY TLT:   $2,468
   BUY SCHP:  $1,058
   BUY BTAL:  $1,058
   Funded by: SELL SGOV $27,500.
2. Remaining $82,500 Tier-3 reserve: HOLD in SGOV — pending VIX and credit-spread confirmation. Deploy remaining sub-tranches only after confirming no systemic event (VIX < 40, spreads not blowing out, no recession/unemployment spike). If systemic event confirmed, pause and reassess.
3. De-risk: no panic selling — structural de-risk is mechanical (DBMF/BTAL crisis alpha, equity exposure already regime-scaled). Hold posture.
Human places all orders; share counts finalized at open.
</orders>
<bull-lag>
In a −20% S&P drawdown with the fund down −16%, the 6.8% vs 8.3% lifetime lag and the 8.6% vs 16.8% bull-era gap have inverted to a tangible advantage — the structure is doing its job. The lost-decade, 2008, and 2020 crash windows are what those figures were computed from; today's −16% fund drawdown vs the S&P's −20% is the risk-premium payout the calmer years were paying for.
</bull-lag>
<audit>
{"date":"2026-10-12","cadence":["daily","weekly","event"],"nav":870000,"current_drawdown":-0.16,"regime_score":0.21,"exposure_multiplier":0.5,"risk_verdict":"scale","risk_scale":0.267,"dip_tier_active":"tier3","dip_newly_fired":"tier3","reserve_before":110000,"tier3_sub1_deployed":27500,"reserve_after":82500,"systemic_event_check":"data unavailable — paused remaining sub-tranches","orders":["SELL SGOV $27,500","BUY RSP $6,346","BUY VXUS $4,231","BUY AVUV $2,821","BUY USMV $2,468","BUY GLD $3,526","BUY DBMF $3,526","BUY TLT $2,468","BUY SCHP $1,058","BUY BTAL $1,058"],"new_idea_in_orders":false}
</audit>
</fund-ops-report>

---

## new_idea_gate

<fund-ops-report cadence="daily|weekly|event" as_of="2026-07-13">
<regime>
Risk-On. Score 0.64 — above the 0.55 risk-on threshold. S&P at 5,850 vs 200-day MA of 5,560 — price +5.2% above the long-term trend filter. Session history not provided — cannot confirm persistence; reporting as "session history unavailable — cannot confirm persistence." Exposure multiplier: 1.0×.
</regime>
<research>
ANALYST NOTE: Proposal to rotate 10% of the book into an AI-semiconductors momentum basket (SOXX + single names) based on 18-month outperformance. No backtest has been run.

BACKTEST GATE APPLIED — PROPOSAL BLOCKED.
Per the fund's hard invariant: every new idea clears the backtest gate before it can inform a real order. 18-month momentum outperformance is precisely the recency bias the gate screens for. Requirements before this idea can proceed:
1. Full backtest 2000-2026 (no look-ahead bias, real or proxy long-history data) through crisis windows: dot-com bust 2000-02, GFC 2008-09, COVID crash 2020, rate shock 2022.
2. Risk-adjusted comparison (CAGR, max DD, Sharpe, Calmar) vs current v3 equity sleeves.
3. Concentration risk assessment — SOXX is heavily weighted toward 3-5 mega-cap names, recreating the concentration risk v3 specifically de-risks against.
4. Single-name exposure adds idiosyncratic risk unsupported by SPIVA evidence.
ROUTING: Idea sent to backtest queue. NOT placed in orders.
</research>
<signals>
S&P −0.85% from 52-week high of 5,900 — market near all-time highs. No trend exit signal for any sleeve. All sleeves hold.
</signals>
<construction>
V3 Balanced targets unchanged at 1.0× exposure: RSP 18% / VXUS 12% / AVUV 8% / USMV 7% / GLD 10% / DBMF 10% / TLT 7% / SCHP 3% / SGOV 22% / BTAL 3%. NAV $1,020,000. No construction change — new idea vetoed at gate.
</construction>
<risk>
Verdict: APPROVE. Risk scale: 1.0. Current drawdown: −1.0% — well inside all thresholds. No caps breached. Note: the AI-semiconductor rotation proposal would also have breached concentration caps (single-name + sector) — double-veto regardless of gate.
</risk>
<cash>
S&P drawdown from 52-week high: −0.85%. No dip tier active (tier 1: −7%). Reserve $220,000 remains in SGOV. No deployment warranted.
</cash>
<rebalance>
Not due — not a quarter-end date. No rebalance action.
</rebalance>
<orders>
No action — all checks clear. AI-semiconductor proposal blocked by backtest gate; does not appear in orders. DCA continues on schedule. Reserve intact.
</orders>
<bull-lag>
It is precisely because calm weeks like this produce proposals like the AI-semiconductor basket — 18 months of outperformance, strong narrative momentum — that the backtest gate exists. The v3 book at 6.8% lifetime vs S&P 8.3%, and 8.6% vs 16.8% in the 2019–2026 bull, already acknowledges trailing a narrow AI-led market. Adding SOXX would double down on the same concentration the strategy hedges against. The lag is real; abandoning the structure to chase it is how it becomes a permanent loss.
</bull-lag>
<watch>
AI-semiconductor / SOXX proposal in backtest queue. If 2000-2026 backtest (through crisis windows) shows risk-adjusted improvement vs current equity sleeves, re-evaluate with the numbers. Monitor: AI capex ROI narrative — if earnings confirm durable ROI and breadth broadens beyond mega-cap AI names, reconsider growth-tilt shift at next IPS review.
</watch>
<audit>
{"date":"2026-07-13","cadence":["daily","weekly","event"],"nav":1020000,"current_drawdown":-0.01,"regime_score":0.64,"exposure_multiplier":1.0,"dip_tier_active":null,"risk_verdict":"approve","risk_scale":1.0,"rebalance_breach":false,"new_idea_proposed":"AI-semiconductors/SOXX momentum basket","gate_result":"blocked — no backtest; routed to backtest queue","new_idea_in_orders":false,"orders":"none"}
</audit>
</fund-ops-report>

---

## month_start_dca

<fund-ops-report cadence="daily|weekly|monthly" as_of="2026-06-01">
<regime>
Risk-On. Score 0.65 — above the 0.55 risk-on threshold. S&P at 5,860 vs 200-day MA of 5,540 — price +5.8% above the long-term trend filter. Session history not provided — cannot confirm persistence; reporting as "session history unavailable — cannot confirm persistence." Exposure multiplier: 1.0×.
</regime>
<signals>
S&P −0.68% from 52-week high of 5,900 — market near all-time highs. No trend exit signal. DBMF and BTAL: hold. No per-sleeve exits warranted.
</signals>
<construction>
V3 Balanced targets at 1.0× exposure: RSP 18% / VXUS 12% / AVUV 8% / USMV 7% / GLD 10% / DBMF 10% / TLT 7% / SCHP 3% / SGOV 22% / BTAL 3%. Monthly DCA tranche 5 of 15: $18,700. Split across 9 risk sleeves pro-rata (weight/0.78):
  RSP   18/78 × $18,700 = $4,315
  VXUS  12/78 × $18,700 = $2,877
  AVUV   8/78 × $18,700 = $1,918
  USMV   7/78 × $18,700 = $1,678
  GLD   10/78 × $18,700 = $2,397
  DBMF  10/78 × $18,700 = $2,397
  TLT    7/78 × $18,700 = $1,678
  SCHP   3/78 × $18,700 =   $719
  BTAL   3/78 × $18,700 =   $719
Total: $18,698 ≈ $18,700. Funded from SGOV DCA sleeve (separate from dip reserve).
</construction>
<risk>
Verdict: APPROVE. Risk scale: 1.0. Current drawdown: −1.0% — well inside all thresholds. No caps breached. DCA deployment at approved size.
</risk>
<cash>
S&P drawdown from 52-week high: −0.68%. No dip tier active (tier 1: −7%). Dip reserve $220,000 remains intact in SGOV — DCA funded from separate DCA budget, not the dip reserve.
</cash>
<rebalance>
Not due — not a quarter-end date (June 1st; quarter-end is June 30th). No rebalance action. Quarter-end drift check due June 30th.
</rebalance>
<performance>
NAV: $1,005,000. Current drawdown: −1.0%. DCA progress: month 5 of 15, tranche deploying today. Deployment on schedule. No full-period benchmark return data provided; SGOV reserve yielding ~4-5% while dip reserve awaits trigger.
</performance>
<orders>
Monthly DCA — Tranche 5 of 15 ($18,700). Human places at open:
  BUY RSP:   $4,315
  BUY VXUS:  $2,877
  BUY AVUV:  $1,918
  BUY USMV:  $1,678
  BUY GLD:   $2,397
  BUY DBMF:  $2,397
  BUY TLT:   $1,678
  BUY SCHP:    $719
  BUY BTAL:    $719
Funded by: SELL SGOV $18,700 (DCA sleeve, not dip reserve). Share counts at limit prices finalized at open.
</orders>
<bull-lag>
Today's DCA tranche deploys into a market −0.68% from its highs in a risk-on regime — the conditions where v3's 6.8% lifetime CAGR vs the S&P's 8.3%, and 8.6% vs 16.8% in the 2019–2026 bull, is most directly a drag. The DCA schedule runs on schedule regardless of regime precisely because time-in-market matters and entry timing is not the edge — the de-concentrated, diversified destination of these dollars is the hedge.
</bull-lag>
<audit>
{"date":"2026-06-01","cadence":["daily","weekly","monthly"],"nav":1005000,"current_drawdown":-0.01,"regime_score":0.65,"exposure_multiplier":1.0,"dip_tier_active":null,"risk_verdict":"approve","risk_scale":1.0,"rebalance_breach":false,"dca_month":5,"dca_amount":18700,"orders":["SELL SGOV $18,700","BUY RSP $4,315","BUY VXUS $2,877","BUY AVUV $1,918","BUY USMV $1,678","BUY GLD $2,397","BUY DBMF $2,397","BUY TLT $1,678","BUY SCHP $719","BUY BTAL $719"],"new_idea_in_orders":false}
</audit>
</fund-ops-report>

---

